"validating" open-source software
От | Jim_Garrett@bd.com |
---|---|
Тема | "validating" open-source software |
Дата | |
Msg-id | OF8D7745EE.F595B51E-ON85256D10.00717344@bd.com обсуждение исходный текст |
Список | pgsql-general |
Is there anyone out there who has used PostgreSQL to store clinical-trial data supporting an application to the FDA for approval of a product? If so, I would love to hear your story. I actually don't use PostgreSQL or any database software directly; rather, I'm posting this on behalf of the R community (in an unofficial capacity; R is a GPL statistical programming environment, see www.r-project.org for more info if curious). The question has been raised on the R discussion list of what, if anything, one must do if one wants R to be the statistical analysis engine behind a submission for FDA approval (of a drug for instance), when the regulating agency has some requirements designed to ensure the integrity of the electronic processes used. (I'm still learning what the FDA's requirements are.) From my limited experience so far I know that there are some specific requirements on database systems and the way organizations use them, while I have yet to find any clear requirements on analysis systems. So it occurs to me that if anyone has addressed this topic regarding a database, where the FDA seems to focus its attention, then dealing with analysis software ought to be a cakewalk in comparison. Please don't feel compelled to tell me about the high quality of open-source software; I'm already a convert. I use R professionally and have found it to be higher quality than any other statistical package I've ever used. Besides, we've already had those philosophical discussions on the R discussion list. Now some of us are going about the more mundane task of figuring out what regulations may require, if anything. Thanks for any information, -Jim Garrett Becton Dickinson Diagnostic Systems Baltimore, Maryland, USA ********************************************************************** This message is intended only for the designated recipient(s). It may contain confidential or proprietary information and may be subject to the attorney-client privilege or other confidentiality protections. If you are not a designated recipient, you may not review, use, copy or distribute this message. If you receive this in error, please notify the sender by reply e-mail and delete this message. Thank you. ***********************************************************************
В списке pgsql-general по дате отправления: